VRTX - Vertex Pharmaceuticals Incorporated

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue1,702,1771,032,336580,415
Cost of Revenue210,460124,51260,987
Gross Profit1,491,717907,824519,428
Operating Expenses
Research Development1,047,690995,922855,506
Selling General and Administrative432,829376,575305,409
Non Recurring1,2622,20650,925
Others---
Total Operating Expenses---
Operating Income or Loss9,936-466,879-692,412
Income from Continuing Operations
Total Other Income/Expenses Net4,130-6,71530,400
Earnings Before Interest and Taxes14,066-473,594-662,012
Interest Expense81,43284,20672,863
Income Before Tax-67,366-557,800-734,875
Income Tax Expense16,66530,3816,958
Minority Interest181,609153,66121,177
Net Income From Continuing Ops-84,031-588,181-741,833
Non-recurring Events
Discontinued Operations---912
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-112,052-556,334-738,555
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-112,052-556,334-738,555